Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (1): 1-8.doi: 10.19982/j.issn.1000-6621.20250421
• Guideline·Standard·Consensus • Previous Articles Next Articles
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences , Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University , Chinese Antituberculosis Association , Editorial Board of the Chinese Journal of Antituberculosis
Received:2025-11-03
Online:2026-01-10
Published:2025-12-31
Supported by:CLC Number:
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences , Lishui Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University , Chinese Antituberculosis Association , Editorial Board of the Chinese Journal of Antituberculosis . Expert consensus on TCM syndrome differentiation, treatment principles, formulas, and herbs for latent tuberculosis infection[J]. Chinese Journal of Antituberculosis, 2026, 48(1): 1-8. doi: 10.19982/j.issn.1000-6621.20250421
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250421
| [1] | 胡鑫洋, 高静韬. 世界卫生组织《2024年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5 (6): 500-504. doi:10.19983/j.issn.2096-8493.2024164. |
| [2] | World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization, 2015. |
| [3] | World Health Organization. WHO calls for urgent action to end TB: Editors notes:About the UN High-level Meeting on TB The United Nations General Assembly High-level. Geneva: World Health Organization, 2018. |
| [4] | World Health Organization. Update of WHO guidelines on the management of latent TB infection. Geneva: World Health Organization, 2019. |
| [5] | Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016, 13(10): e1002152. doi:10.1371/journal.pmed.1002152. |
| [6] | 高磊, 张慧, 胡茂桂, 等. 基于多中心调查数据和空间统计模型的全国结核分枝杆菌潜伏感染率估算. 中国防痨杂志, 2022, 44(1): 54-59. doi:10.19982/j.issn.1000-6621.20210661. |
| [7] |
Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol, 1974, 99(2): 131-138. doi:10.1093/oxfordjournals.aje.a121593.
pmid: 4810628 |
| [8] |
Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect, 1997, 119(2): 183-201. doi:10.1017/s0950268897007917.
pmid: 9363017 |
| [9] | 郭同磊, 辛赫男, 高磊. 《世界卫生组织结核病整合指南模块1: 结核病预防性治疗》解读. 中国防痨杂志, 2023, 45(8): 723-727. doi:10.19982/j.issn.1000-6621.20230199. |
| [10] | 马艳, 陆伟, 高磊, 等. 终止结核病流行须加强结核分枝杆菌潜伏感染高危人群筛查和预防性治疗的管理. 中国防痨杂志, 2022, 44(3): 209-214. doi:10.19982/j.issn.1000-6621.20220008. |
| [11] | 马艳, 陆伟, 成诗明. 结核分枝杆菌潜伏感染现状及防控对策. 解放军医学杂志, 2023, 48(6): 634-642. doi:10.11855/j.issn.0577-7402.2023.06.0634. |
| [12] | 马艳, 成诗明. 加速我国结核潜伏感染筛查与预防性治疗的建议. 实用医学杂志, 2023, 39(11): 1335-1340. doi:10.3969/j.issn.1006-5725.2023.11.003. |
| [13] | 中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021: 5. |
| [14] | 赵雁林, 陆伟, 沙巍. 结核潜伏感染人群预防性治疗手册. 北京: 人民卫生出版社, 2022: 4. |
| [15] |
Zenner D, Beer N, Harris RJ, et al. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. Ann Intern Med, 2017, 167(4): 248-255. doi:10.7326/M17-0609.
pmid: 28761946 |
| [16] | Gao L, Zhang H, Xin H, et al. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study. Eur Respir J, 2018, 52(6): 1801470. doi:10.1183/13993003.01470-2018. |
| [17] | Xin H, Cao X, Zhang H, et al. Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J, 2022, 60(1): 2102359. doi:10.1183/13993003.02359-2021. |
| [18] | Ruan QL, Huang XT, Yang QL, et al. Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial. Clin Microbiol Infect, 2021, 27(4): 576-582. doi:10.1016/j.cmi.2020.06.008. |
| [19] | 翁丽霞, 王勇. 学校涂阳肺结核密切接触者筛查及预防性服药效果分析. 国际流行病学传染病学杂志, 2014, 41(4): 258-260. doi:10.3760/cma.issn.1673-4149.2014.04.011. |
| [20] |
Xin H, Zhang H, Yang S, et al. 5-Year Follow-up of Active Tuberculosis Development From Latent Infection in Rural China. Clin Infect Dis, 2020, 70(5): 947-950. doi:10.1093/cid/ciz581.
pmid: 31253988 |
| [21] | 祖之鹏, 陈海婷, 陈园园, 等. 耐多药结核病患者密切接触者抗结核预防性治疗研究进展. 中国防痨杂志, 2025, 47(11): 1528-1534. doi:10.19982/j.issn.1000-6621.20250299. |
| [22] | Swindells S, Ramchandani R, Gupta A, et al. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. N Engl J Med, 2019, 380(11): 1001-1011. doi:10.1056/NEJMoa1806808. |
| [23] | 中国防痨协会. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识. 中国防痨杂志, 2021, 43(9): 874-878. doi:10.3969/j.issn.1000-6621.2021.09.004. |
| [24] | 师晓晶, 郭建花, 王鑫, 等. 石家庄市结核分枝杆菌潜伏感染者预防性治疗接受度及影响因素研究. 中国防痨杂志, 2025, 47(6): 746-752. doi:10.19982/j.issn.1000-6621.20240591. |
| [25] | 佟琳, 马艳, 范逸品, 等. 基于文献的清肺排毒汤组方治疫应用规律探讨. 中医杂志, 2021, 62(21): 1877-1881. doi:10.13288/j.11-2166/r.2021.21.007. |
| [26] | 孙巧思, 胡镜清, 刘理想. 论中医学疫病防治特色. 中国中医基础医学杂志, 2021, 27(1): 42-45, 49. |
| [27] | 曹玉清, 尚希钰, 熊一白, 等. 青蒿素研发的成功经验对结核病防治的借鉴与启示. 结核与肺部疾病杂志, 2023, 4(6): 442-448. doi:10.19983/j.issn.2096-8493.20230089. |
| [28] | Xiong Y, Bao L, Ma Y, et al. Wen-Yi and Chinese medicine: Why we need to pay attention? Sci Bull (Beijing), 2024, 69(11): 1617-1622. doi:10.1016/j.scib.2024.03.059. |
| [29] | 朱凌凌, 段逸山, 高驰, 等. 肺痨病名源流考. 中华中医药杂志, 2018, 33(7): 2994-2999. |
| [30] | 彭博文, 李董男. 清代医家“扶正避邪”防疫思想和方法探析. 中国中医基础医学杂志, 2024, 30(6): 924-928. doi:10.19945/j.cnki.issn.1006-3250.2024.06.001. |
| [31] | 马希骏, 杜沁圆, 张义敏, 等. 《温疫论》疫病论治中补法运用探析. 北京中医药大学学报, 2023, 46(3): 331-335. doi:10.3969/j.issn.1006-2157.2023.03.008. |
| [32] | 严家凤. 中医“正气存内,邪不可干”的防疫思维释义. 医学与哲学, 2022, 43(1): 63-66. doi:10.12014/j.issn.1002-0772.2022.01.14. |
| [33] | 王国为, 杨威, 黄毅, 等. 《素问遗篇》疫病防治策略研究. 亚太传统医药, 2020, 16(10): 7-10. doi:10.11954/ytctyy.202010003. |
| [34] | 张闯, 张夏梦, 夏雨果, 等. 基于“未病先防,既病防变,瘥后防复”理论探讨疫病的中医防治. 西部中医药, 2021, 34(9): 1-4. doi:10.12174/j.issn.1004-6852.2021.09.01. |
| [35] | 徐梦丹, 杨长福, 林昶, 等. 从“未病先防”与“既病防变”探讨新冠肺炎的中医防治. 贵州中医药大学学报, 2020, 42(2): 7-10, 15. doi:10.16588/j.cnki.issn1002-1108.2020.02.002. |
| [36] | 蔡华珠, 洪菲萍, 纪立金, 等. “正气存内, 邪不可干”的内涵及运用探析. 中华中医药杂志, 2015, 30(4): 987-989. |
| [37] | 丰银平, 张尊敬, 蔡秋杰, 等. 基于伏邪理论探讨结核分枝杆菌潜伏感染辨治思路. 中国防痨杂志, 2025, 47(10): 1249-1253. doi:10.19982/j.issn.1000-6621.20250327. |
| [38] | 穆婷婷, 张旭阳, 马艳, 等. 基于《理虚元鉴》“三本二统”治虚理论论治肺痨. 中国防痨杂志, 2025, 47(11): 1522-1527. doi:10.19982/j.issn.1000-6621.20250329. |
| [39] | 邱磊, 张少言, 郭晓燕, 等. 化疗方案加芩部丹片治疗复治涂阳肺结核患者的临床价值. 中国防痨杂志, 2020, 42(2): 108-114. doi:10.3969/j.issn.1000-6621.2020.02.006. |
| [40] | 费婉婉, 鹿振辉, 黄星, 等. 基于“肺与大肠相表里”探讨肠道菌群与肺结核关系的研究进展. 中国防痨杂志, 2022, 44(5): 500-504. doi:10.19982/j.issn.1000-6621.20210582. |
| [41] | 庄丽, 马子风, 蒋雨薇, 等. 基于网络药理学的中药组方“芩部丹”治疗肺结核作用机制研究. 中国防痨杂志, 2022, 44(3): 273-283. doi:10.19982/j.issn.1000-6621.20210572. |
| [42] | 彭草云, 阮月芳, 钱惠江. 初治肺结核患者体质与T淋巴细胞亚群关系的研究. 中国现代医生, 2023, 61(21): 1-4, 14. doi:10.3969/j.issn.1673-9701.2023.21.001. |
| [43] | 郭净, 刘忠达, 张尊敬, 等. 老年肺结核患者中医药诊治研究进展. 中国防痨杂志, 2024, 46(11): 1406-1409. doi:10.19982/j.issn.1000-6621.20240192. |
| [44] | 丘海先. 中医药治疗肺结核研究进展. 亚太传统医药, 2015, 11(12): 43-44. doi:10.11954/ytctyy.201512019. |
| [45] | 傅景华, 陈心智. 黄帝内经素问. 北京: 中医古籍出版社, 1997: 2. |
| [46] | 赵明芬, 安冬青, 汪建萍. 试论伏邪理论的源流及发展. 中医杂志, 2016, 57(3): 189-192. doi:10.13288/j.11-2166/r.2016.03.003. |
| [47] | 吴文军, 刘西洋, 冯全生, 等. 试论伏气学说之“伏”. 中华中医药杂志, 2021, 36(10): 5804-5806. |
| [48] | 杨映映, 田传玺, 赵林华. 论伏邪致病的因机证治. 长春中医药大学学报, 2024, 40(11): 1189-1191. doi:10.13463/j.cnki.cczyy.2024.11.003. |
| [49] | 戴志澄, 肖东楼, 万利亚. 中国防痨史. 北京: 人民卫生出版社, 2013. |
| [50] | 刘剑君, 王黎霞. 现代结核病学. 北京: 人民卫生出版社, 2022. |
| [51] | 梁晨, 唐神结, 林明贵. 结核病综合治疗研究进展. 结核与肺部疾病杂志, 2024, 5(1): 70-80. doi:10.19983/j.issn.2096-8493.20230112. |
| [52] | 付子珊, 杨宇峰, 石岩. 肺痨病因病机理论框架研究. 河北中医, 2021, 43(5): 856-859. doi:10.3969/j.issn.1002-2619.2021.05.033. |
| [53] |
Gao L, Lu W, Bai L, et al. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2015, 15(3): 310-319. doi:10.1016/S1473-3099(14)71085-0.
pmid: 25681063 |
| [54] | 钟涛, 詹广兴, 范玉铮, 等. 深圳市南山区高危人群结核菌潜伏感染情况及影响因素. 中国热带医学, 2020, 20(8): 702-709, 716. doi:10.13604/j.cnki.46-1064/r.2020.08.03. |
| [55] | 李晓雪, 肖筱, 徐春华, 等. 活动性结核病患者密切接触者结核分枝杆菌潜伏感染率的Meta分析. 结核与肺部疾病杂志, 2024, 5(5): 404-414. doi:10.19983/j.issn.2096-8493.2024128. |
| [56] | Zhu Z, Shen W, Hu J, et al. Risk factors for latent tuberculosis infection clustering among the elderly: a population-based cross-sectional study in Eastern China. BMC Infect Dis, 2025, 25(1):368. doi: 10.1186/s12879-025-10743-7. |
| [57] | 宋慧荣, 倪诚, 王济, 等. 老年生理与体质特点辨析及其临床意义. 天津中医药, 2021, 38(9): 1089-1092. doi:10.11656/j.issn.1672-1519.2021.09.01. |
| [58] | 黄小原, 翟双庆. 论膜原为周身之间隙. 中医杂志, 2023, 64(4): 422-424. doi:10.13288/j.11-2166/r.2023.04.019. |
| [59] | 马雪颜, 秦雪颖, 谷晓红. 膜系理论探讨. 北京中医药大学学报, 2023, 46(7): 931-936. doi:10.3969/j.issn.1006-2157.2023.07.007. |
| [60] | 杨晨曦, 鲁明源. 三焦与膜原内涵及其关系辨析. 中华中医药杂志, 2022, 37(10): 5703-5707. |
| [61] | 张永前. 中医体质学的中医哲学“辨证法”内涵探讨. 中医研究, 2014, 27(12): 7-8. doi:10.3969/j.issn.1001-6910.2014.12.04. |
| [62] | 朱燕波. 中医体质分类判定与兼夹体质的综合评价. 中华中医药杂志, 2012, 27(1): 37-39. |
| [63] | 冯立慧, 李燕秋, 林婧, 等. HIV/AIDS患者ART过程中血红蛋白水平对免疫学失败、预后的影响[J/OL]. 中国皮肤性病学杂志: 1-17 [2025-11-07]. https://doi.org/10.13735/j.cjdv.1001-7089.202501001.[网络预发表]. |
| [64] | 夏露, 卢水华, 刘平. 中药对结核病免疫调控机制的研究进展. 中国防痨杂志, 2020, 42 (2):168-172. doi:10.3969/j.issn.1000-6621.2020.02.016. |
| [65] | 洪伟玲, 王潇, 施静怡, 等. 抗结核中药的作用机制研究进展. 中医药学报, 2024, 52(4): 91-98. doi:10.19664/j.cnki.1002-2392.240081. |
| [66] | 李佳颖, 王晓婧, 尚家起, 等. 抗分枝杆菌植物天然产物研究进展. 中国抗生素杂志, 2022, 47(12): 1225-1231. doi:10.3969/j.issn.1001-8689.2022.12.001. |
| [67] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4):376-378. doi:10.19983/j.issn.2096-8493.2024022. |
| [1] | Jiangxi Chest Hospital/Jiangxi Provincial Key Laboratory of Tuberculosis , Guangzhou National Laboratory , Chinese Antituberculosis Association . Expert consensus on the application of host biomarkers for tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(1): 9-20. |
| [2] | National Clinical Research Center for Infectious Diseases , Peking University Shenzhen Hospital , Shenzhen Key Laboratory of Immunity and Inflammatory Diseases , The Third People’s Hospital of Shenzhen , Expert Consensus Group on the Etiology and Diagnosis of Erythema Nodosum . Expert consensus on the etiology and diagnosis of erythema nodosum (2025 version) [J]. Chinese Journal of Antituberculosis, 2025, 47(9): 1126-1134. |
| [3] | Tuberculosis Control Branch of Chinese Antituberculosis Association, Standardization Professional Branch of Chinese Antituberculosis Association, Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association. Expert consensus on the application of Mycobacterium tuberculosis infection detection technologies [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 813-829. |
| [4] | Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Beijing Chest Hospital Capital Medlical University/Beijing Tuberculosis and Thoracic Tumor Research Institute. Expert consensus on all-oral short-course therapy for drug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 830-839. |
| [5] | Yu Huimin, Zheng Hui, Liu Eryong, Huang Fei, Wu Dan, Yin Zundong. Research progress on immunization strategies for tuberculosis vaccines [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 930-939. |
| [6] | Shi Xiaojing, Guo Jianhua, Wang Xin, Zhao Qingran, Wang Yuhan. A study on the acceptance of preventive treatment and its influencing factors among latent tuberculosis infectors in Shijiazhuang City [J]. Chinese Journal of Antituberculosis, 2025, 47(6): 746-752. |
| [7] | Tuberculosis Basic Professional Branch, Chinese Antituberculosis Association. Expert consensus on the standardization of broth microdilution method for drug susceptibility testing of Mycobacterium tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 535-545. |
| [8] | Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of urological tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 546-558. |
| [9] | Liu Qiao, Li Zhongqi, Zhu Limei, Lu Wei. Study on the status, problems and countermeasures of tuberculosis control service system in China [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 559-568. |
| [10] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
| [11] | Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital , Editorial Board of Chinese Journal of Antituberculosis , Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange , Promotive Association for Medical and Health Care . Expert consensus on multidisciplinary diagnosis and treatment of tuberculous peritonitis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 243-257. |
| [12] | Feng Yinping, Zhang Zunjing, Cai Qiujie, Wang Xiaomeng, Ma Yan, Liu Zhongda, Gao Lei. Exploring diagnostic and therapeutic approaches for latent tuberculosis infection based on the theory of hidden pathogen (Fu Xie) [J]. Chinese Journal of Antituberculosis, 2025, 47(10): 1249-1253. |
| [13] | Expert Consensus on the Diagnosis and Treatment of Spinal Tuberculosis Combined with HIV/AIDS Patients Group, Combined with HIV/AIDS Patients Group Chinese Antituberculosis Association, Chinese Antituberculosis Association of STD and AIDS Prevention and Control, the Western China Bone Tuberculosis Alliance, the North China Bone the North China Bone. Expert consensus on diagnosis and treatment of spinal tuberculosis with HIV/AIDS (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 1-11. |
| [14] | Li Zhili, Liu Yuhong. Interpretation of WHO consolidated guidelines on tuberculosis. Module 6: tuberculosis and comorbidities-HIV [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 869-873. |
| [15] | Fu Keyan, Zhu Bangzheng, Ye Jian. Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 823-829. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.